Shandong Weigao Group Med... (SHWGY)
Shandong Weigao Medical Polymer Statistics
Share Statistics
Shandong Weigao Medical Polymer has 284.8M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 284.8M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 611.8M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 3.88 and the forward PE ratio is null. Shandong Weigao Medical Polymer's PEG ratio is -0.15.
| PE Ratio | 3.88 |
| Forward PE | n/a |
| PS Ratio | 0.59 |
| Forward PS | n/a |
| PB Ratio | 0.35 |
| P/FCF Ratio | 3.68 |
| PEG Ratio | -0.15 |
Enterprise Valuation
Shandong Weigao Medical Polymer has an Enterprise Value (EV) of 28.26B.
| EV / Sales | 2.14 |
| EV / EBITDA | 9.26 |
| EV / EBIT | 10.1 |
| EV / FCF | 13.38 |
Financial Position
The company has a current ratio of 2.46, with a Debt / Equity ratio of 0.19.
| Current Ratio | 2.46 |
| Quick Ratio | 2.13 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 1.37 |
| Debt / FCF | 1.97 |
| Interest Coverage | 8.42 |
Financial Efficiency
Return on Equity is 8.92% and Return on Invested Capital is 6.97%.
| Return on Equity | 8.92% |
| Return on Assets | 5.95% |
| Return on Invested Capital | 6.97% |
| Revenue Per Employee | $1.04M |
| Profits Per Employee | $157.39K |
| Employee Count | 12,719 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.64 |
Taxes
| Income Tax | 307.58M |
| Effective Tax Rate | 12.98% |
Stock Price Statistics
The stock price has increased by 21.31% in the last 52 weeks. The beta is 0.59, so Shandong Weigao Medical Polymer's price volatility has been higher than the market average.
| Beta | 0.59 |
| 52-Week Price Change | 21.31% |
| 50-Day Moving Average | 2.8 |
| 200-Day Moving Average | 2.45 |
| Relative Strength Index (RSI) | 53.74 |
| Average Volume (20 Days) | 2.31K |
Income Statement
In the last 12 months, Shandong Weigao Medical Polymer had revenue of 13.23B and earned 2B in profits. Earnings per share was 7.04.
| Revenue | 13.23B |
| Gross Profit | 6.64B |
| Operating Income | 2.3B |
| Net Income | 2B |
| EBITDA | 3.05B |
| EBIT | 2.64B |
| Earnings Per Share (EPS) | 7.04 |
Balance Sheet
The company has 6.99B in cash and 4.17B in debt, giving a net cash position of 2.82B.
| Cash & Cash Equivalents | 6.99B |
| Total Debt | 4.17B |
| Net Cash | 2.82B |
| Retained Earnings | 18.63B |
| Total Assets | 33.67B |
| Working Capital | 11.05B |
Cash Flow
In the last 12 months, operating cash flow was 2.8B and capital expenditures -685.66M, giving a free cash flow of 2.11B.
| Operating Cash Flow | 2.8B |
| Capital Expenditures | -685.66M |
| Free Cash Flow | 2.11B |
| FCF Per Share | 1.86 |
Margins
Gross margin is 50.21%, with operating and profit margins of 17.36% and 15.13%.
| Gross Margin | 50.21% |
| Operating Margin | 17.36% |
| Pretax Margin | 17.91% |
| Profit Margin | 15.13% |
| EBITDA Margin | 23.06% |
| EBIT Margin | 17.36% |
| FCF Margin | 15.97% |
Dividends & Yields
SHWGY pays an annual dividend of $0.15, which amounts to a dividend yield of 4.12%.
| Dividend Per Share | $0.15 |
| Dividend Yield | 4.12% |
| Dividend Growth (YoY) | 20.45% |
| Payout Ratio | 58.4% |
| Earnings Yield | 25.76% |
| FCF Yield | 6.8% |
Analyst Forecast
Currently there are no analyst rating for SHWGY.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on May 9, 2011. It was a forward split with a ratio of 2:1.
| Last Split Date | May 9, 2011 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 1.83 |
| Piotroski F-Score | 5 |